Publication Cover
Nutritional Neuroscience
An International Journal on Nutrition, Diet and Nervous System
Volume 26, 2023 - Issue 10
454
Views
1
CrossRef citations to date
0
Altmetric
Review

An insight into the neuroprotective effects and molecular targets of pomegranate (Punica granatum) against Alzheimer’s disease

, , , & ORCID Icon

References

  • Gupta S, Nair A, Jhawat V, Mustaq N, Sharma A, Dhanawat M, Khan SA. Unwinding complexities of diabetic Alzheimer by potent novel molecules. Am J Alzheimer's Dis Other Dementias. 2020;35:1533317520937542.
  • Husain A, Al Balushi K, Akhtar MJ, Khan SA. Coumarin linked heterocyclic hybrids: a promising approach to develop multi target drugs for Alzheimer's disease. J Mol Struct. 2021;1241:130618.
  • Talesa VN. Acetylcholinesterase in Alzheimer's disease. Mech Ageing Dev. 2001;122(16):1961–9.
  • Sharma P, Sharma A, Fayaz F, Wakode S, Pottoo FH. Biological signatures of Alzheimer’s disease. Curr Top Med Chem. 2020;20(9):770–81.
  • Rahimi HR, Arastoo M, Ostad SN. A comprehensive review of Punica granatum (pomegranate) properties in toxicological, pharmacological, cellular and molecular biology researches. Iran J Pharm Res. 2012;11(2):385.
  • Jurenka J. Therapeutic applications of pomegranate (Punica granatum L.): a review. Altern Med Rev. 2008;13(2):128–44.
  • Shaygannia E, Bahmani M, Zamanzad B, Rafieian-Kopaei M. A review study on Punica granatum L. J Evid Based Complem Altern Med. 2016;21(3):221–7.
  • Melgarejo-Sánchez P, Núñez-Gómez D, Martínez-Nicolás JJ, Hernández F, Legua P, Melgarejo P. Pomegranate variety and pomegranate plant part, relevance from bioactive point of view: a review. Bioresources Bioprocessing. 2021;8(1):1–29.
  • Cannataro R, Fazio A, La Torre C, Caroleo MC, Cione E. Polyphenols in the Mediterranean diet: from dietary sources to microRNA modulation. Antioxidants. 2021;10(2). DOI: 10.3390/antiox10020328.
  • Berry EM, Arnoni Y, Aviram M. The middle eastern and biblical origins of the Mediterranean diet. Public Health Nutr. 2011;14(12A):2288–95.
  • Al Said F, Al-Yahyai R, Opara U. Traditional cultivation of pomegranate in Oman. In II all Africa horticulture congress, 1007, 2012; pp 549–55.
  • Singh V, Sharma S, Khare V. Medicinal plants from Ujjain district Madhya Pradesh-part II. Indian Drugs Pharm Ind. 1980;1980(5):7–12.
  • Jain S, Puri H. Ethnomedicinal plants of Jaunsar-Bawar hills, Uttar Pradesh, India. J Ethnopharmacol. 1984;12(2):213–22.
  • Siang ST. Use of combined traditional Chinese and Western medicine in the management of burns. Panminerva Med. 1983;25(3):197–202.
  • Arseculeratne SN, Gunatilaka AL, Panabokke RG. Studies on medicinal plants of Sri Lanka. Part 14: toxicity of some traditional medicinal herbs. J Ethnopharmacol. 1985;13(3):323–35.
  • Arun N, Singh D. Punica granatum: a review on pharmacological and therapeutic properties. Int J Pharm Sci Res. 2012;3(5):1240.
  • Bagri P, Ali M, Aeri V, Bhowmik M, Sultana S. Antidiabetic effect of Punica granatum flowers: effect on hyperlipidemia, pancreatic cells lipid peroxidation and antioxidant enzymes in experimental diabetes. Food Chem Toxicol. 2009;47(1):50–54.
  • Tang D, Liu L, Ajiakber D, Ye J, Xu J, Xin X, Aisa HA. Anti-diabetic effect of Punica granatum flower polyphenols extract in type 2 diabetic rats: activation of Akt/GSK-3β and inhibition of IRE1α-XBP1 pathways. Front Endocrinol. 2018;9:586.
  • Huang TH, Peng G, Kota BP, Li GQ, Yamahara J, Roufogalis BD, Li Y. Anti-diabetic action of Punica granatum flower extract: activation of PPAR-γ and identification of an active component. Toxicol Appl Pharmacol. 2005;207(2):160–9.
  • Vidal A, Fallarero A, Peña BR, Medina ME, Gra B, Rivera F, et al. Studies on the toxicity of Punica granatum L. Punicaceae) whole fruit extracts. J Ethnopharmacol. 2003;89(2-3):295–300.
  • Ismail T, Sestili P, Akhtar S. Pomegranate peel and fruit extracts: a review of potential anti-inflammatory and anti-infective effects. J Ethnopharmacol. 2012;143(2):397–405.
  • Ali N, Jamil A, Shah S, Shah I, Ahmed G, Junaid M, Ahmed Z. Parasiticidal and brine shrimp cytotoxicity potential of crude methanolic extract of rind of Punica granatum Linn against round worms and tape worms. Pakistan J Pharmacuetical Sci. 2015;28(3):959–62.
  • Mo J, Panichayupakaranant P, Kaewnopparat N, Nitiruangjaras A, Reanmongkol W. Topical anti-inflammatory and analgesic activities of standardized pomegranate rind extract in comparison with its marker compound ellagic acid in vivo. J Ethnopharmacol. 2013;148(3):901–8.
  • Rathod N, Biswas D, Chitme H, Ratna S, Muchandi I, Chandra R. Anti-urolithiatic effects of Punica granatum in male rats. J Ethnopharmacol. 2012;140(2):234–8.
  • Galasko D, Montine TJ. Biomarkers of oxidative damage and inflammation in Alzheimer’s disease. Biomark Med. 2010;4(1):27–36.
  • Schwab C, McGeer PL. Inflammatory aspects of Alzheimer disease and other neurodegenerative disorders. J Alzheimers Disease. 2008;13(4):359–69. DOI: 10.3233/jad-2008-13402.
  • Amer OS, Dkhil MA, Hikal WM, Al-Quraishy S. Antioxidant and anti-inflammatory activities of pomegranate (Punica granatum) on Eimeria papillata-induced infection in mice. BioMed Res Int. 2015;2015:219670.
  • Doostkam A, Bassiri-Jahromi S, Iravani K. Punica granatum with multiple effects in chronic diseases. Int J Fruit Sci. 2020;20(3):471–94. DOI: 10.1080/15538362.2019.1653809.
  • Shukla M, Gupta K, Rasheed Z, Khan KA, Haqqi TM. Consumption of hydrolyzable tannins-rich pomegranate extract suppresses inflammation and joint damage in rheumatoid arthritis. Nutrition. 2008;24(7-8):733–43.
  • Pirzadeh M, Caporaso N, Rauf A, Shariati MA, Yessimbekov Z, Khan MU, et al. Pomegranate as a source of bioactive constituents: a review on their characterization, properties and applications. Crit Rev Food Sci Nutr. 2021;61(6): 982–99.
  • Celiksoy V, Moses RL, Sloan AJ, Moseley R, Heard CM. Evaluation of the in vitro oral wound healing effects of pomegranate (Punica granatum) rind extract and punicalagin, in combination with Zn (II). Biomolecules. 2020;10(9):1234.
  • Afaq F, Khan N, Syed DN, Mukhtar H. Oral feeding of pomegranate fruit extract inhibits early biomarkers of UVB radiation-induced carcinogenesis in SKH-1 hairless mouse epidermis. Photochem Photobiol. 2010;86(6):1318–26.
  • George J, Singh M, Srivastava AK, Bhui K, Shukla Y. Corrigendum to “synergistic growth inhibition of mouse skin tumors by pomegranate fruit extract and diallyl sulfide: evidence for inhibition of activated MAPKs/NF-κB and reduced cell proliferation” [food chem. toxicol. 49 (2011) 1511-20]. Food Chem Toxicol. 2019;133:110784. DOI: 10.1016/j.fct.2019.110784.
  • Asmaa MJS, Ali AJH, Farid JM, Azman S. Growth inhibitory effects of crude pomegranate peel extract on chronic myeloid leukemia, K562 cells. Int J Appl Basic Med Res. 2015;5(2):100.
  • Toda K, Ueyama M, Tanaka S, Tsukayama I, Mega T, Konoike Y, et al. Ellagitannins from Punica granatum leaves suppress microsomal prostaglandin E synthase-1 expression and induce lung cancer cells to undergo apoptosis. Biosci, Biotechnol, Biochem. 2020;84(4):757–63.
  • Dahlawi H, Jordan-Mahy N, Clench M, McDougall GJ, Maitre CL. Polyphenols are responsible for the proapoptotic properties of pomegranate juice on leukemia cell lines. Food Sci Nutrition. 2013;1(2):196–208. DOI: 10.1002/fsn3.26.
  • Tamborlin L, Sumere BR, de Souza MC, Pestana NF, Aguiar AC, Eberlin MN, et al. Characterization of pomegranate peel extracts obtained using different solvents and their effects on cell cycle and apoptosis in leukemia cells. Food Sci Nutrition. 2020;8(10):5483–96. DOI: 10.1002/fsn3.1831.
  • Sun R, Zhang J, Chen L, Zhang N, Wang X, Chen W.. Punica granatum extract inhibits bladder cancer cell viability, invasion and migration through down-regulation of HOXD10 signalling pathway. Dokl Biochem Biophys. 2021;497(1):130–6.
  • Moga MA, Dimienescu OG, Bălan A, Dima L, Toma SI, Bîgiu NF, Blidaru A. Pharmacological and therapeutic properties of Punica granatum phytochemicals: possible roles in breast cancer. Molecules. 2021;26(4):1054.
  • Sudha T, Mousa DS, El-Far AH, Mousa SA. Pomegranate (Punica granatum) fruit extract suppresses cancer progression and tumor angiogenesis of pancreatic and colon cancer in chick chorioallantoic membrane model. Nutr Cancer. 2020: 73(8):1350–56.
  • Chaves FM, Pavan ICB, da Silva LGS, de Freitas LB, Rostagno MA, Antunes AEC, et al. Pomegranate juice and peel extracts are able to inhibit proliferation, migration and colony formation of prostate cancer cell lines and modulate the Akt/mTOR/S6K signaling pathway. Plant Foods Hum Nutr. 2020;75(1):54–62.
  • Yuan T, Ma H, Liu W, Niesen DB, Shah N, Crews R, et al. Pomegranate's neuroprotective effects against Alzheimer's disease are mediated by urolithins, its ellagitannin-gut microbial derived metabolites. ACS Chem Neurosci. 2016;7(1):26–33. DOI: 10.1021/acschemneuro.5b00260.
  • Spencer JP, Vauzour D, Rendeiro C. Flavonoids and cognition: the molecular mechanisms underlying their behavioural effects. Arch Biochem Biophys. 2009;492(1–2):1–9. DOI: 10.1016/j.abb.2009.10.003.
  • Landete J. Ellagitannins, ellagic acid and their derived metabolites: a review about source, metabolism, functions and health. Food Res Int. 2011;44(5):1150–60.
  • Akıncıoğlu H, Gülçin İ. Potent acetylcholinesterase inhibitors: potential drugs for Alzheimer’s disease. Mini Rev Med Chem. 2020;20(8):703–15.
  • Jazayeri SB, Amanlou A, Ghanadian N, Pasalar P, Amanlou M. A preliminary investigation of anticholinesterase activity of some Iranian medicinal plants commonly used in traditional medicine. DARU J Pharmaceutical Sci. 2014;22(1):1–5.
  • Bekir J, Mars M, Souchard JP, Bouajila J. Assessment of antioxidant, anti-inflammatory, anti-cholinesterase and cytotoxic activities of pomegranate (Punica granatum) leaves. Food Chem Toxicol. 2013;55:470–5.
  • Mathew M, Subramanian S. In vitro screening for anti-cholinesterase and antioxidant activity of methanolic extracts of ayurvedic medicinal plants used for cognitive disorders. PloS One. 2014;9(1):e86804.
  • Bekir J, Cazaux S, Mars M, Bouajila J. In vitro anti-cholinesterase and anti-hyperglycemic activities of flowers extracts from seven pomegranate varieties. Ind Crops Prod. 2016;81:176–9.
  • Kiasalari Z, Heydarifard R, Khalili M, Afshin-Majd S, Baluchnejadmojarad T, Zahedi E, et al. Ellagic acid ameliorates learning and memory deficits in a rat model of Alzheimer’s disease: an exploration of underlying mechanisms. Psychopharmacology. 2017;234(12):1841–52.
  • Morzelle MC, Salgado JM, Telles M, Mourelle D, Bachiega P, Buck HS, Viel TA. Neuroprotective effects of pomegranate peel extract after chronic infusion with amyloid-β peptide in mice. PLoS One. 2016;11(11):e0166123, DOI: 10.1371/journal.pone.0166123.
  • Amri Z, Ghorbel A, Turki M, Akrout FM, Ayadi F, Elfeki A, Hammami M. Effect of pomegranate extracts on brain antioxidant markers and cholinesterase activity in high fat-high fructose diet induced obesity in rat model. BMC Complement Altern Med. 2017;17(1):339. DOI: 10.1186/s12906-017-1842-9.
  • Cano-Lamadrid M, Tkacz K, Turkiewicz IP, Nowicka P, Hernández F, Lech K, et al. Inhibition of enzymes associated with metabolic and neurological disorder by dried pomegranate sheets as a function of pomegranate cultivar and fruit puree. J Sci Food Agric. 2021;101(6):2294–303. DOI: 10.1002/jsfa.10850.
  • Sisodia SS, Price DL. Role of the beta-amyloid protein in Alzheimer's disease. FASEB J. 1995;9(5):366–70. DOI: 10.1096/fasebj.9.5.7896005.
  • Vassar R. Beta-secretase (BACE) as a drug target for Alzheimer's disease. Adv Drug Delivery Rev. 2002;54(12):1589–602. DOI: 10.1016/s0169-409x(02)00157-6.
  • Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, Denis P, et al. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science. 1999;286(5440):735–41. DOI: 10.1126/science.286.5440.735.
  • Kwak HM, Jeon SY, Sohng BH, Kim JG, Lee JM, Lee KB, et al. S. beta-secretase (BACE1) inhibitors from pomegranate (Punica granatum) husk. Arch Pharm Res. 2005;28(12):1328–32. DOI: 10.1007/bf02977896.
  • Hartman RE, Shah A, Fagan AM, Schwetye KE, Parsadanian M, Schulman RN, et al. Pomegranate juice decreases amyloid load and improves behavior in a mouse model of Alzheimer's disease. Neurobiol Dis. 2006;24(3):506–15. DOI: 10.1016/j.nbd.2006.08.006.
  • Feng Y, Yang SG, Du XT, Zhang X, Sun XX, Zhao M, et al. Ellagic acid promotes Abeta42 fibrillization and inhibits Abeta42-induced neurotoxicity. Biochem Biophys Res Commun. 2009;390(4):1250–4. DOI: 10.1016/j.bbrc.2009.10.130.
  • Sackmann C, Hallbeck M. Oligomeric amyloid-β induces early and widespread changes to the proteome in human iPSC-derived neurons. Sci Rep. 2020;10(1):6538. DOI: 10.1038/s41598-020-63398-6.
  • Ahmed AH, Subaiea GM, Eid A, Li L, Seeram NP, Zawia NH. Pomegranate extract modulates processing of amyloid-β precursor protein in an aged Alzheimer's disease animal model. Curr Alzheimer Res. 2014;11(9):834–43.
  • Subash S, Braidy N, Essa MM, Zayana AB, Ragini V, Al-Adawi S, et al. Long-term (15 mo) dietary supplementation with pomegranates from Oman attenuates cognitive and behavioral deficits in a transgenic mice model of Alzheimer's disease. Nutrition. 2015;31(1):223–9. DOI: 10.1016/j.nut.2014.06.004.
  • Kasi PB, Kotormán M. Among commercially available fruit juices, pomegranate is the most effective inhibitor of PMS-trypsin amyloid-like fibrils formation. Nat Prod Commun. 2019;14(6):1934578X19859127. DOI: 10.1177/1934578(19859127.
  • Onuska KM. The dual role of microglia in the progression of Alzheimer's disease. J Neurosci. 2020;40(8):1608–10. DOI: 10.1523/jneurosci.2594-19.2020.
  • Passamonti L, Tsvetanov KA, Jones PS, Bevan-Jones WR, Arnold R, Borchert RJ, et al. Neuroinflammation and functional connectivity in Alzheimer's disease: interactive influences on cognitive performance. J Neurosci. 2019;39(36):7218–26. DOI: 10.1523/jneurosci.2574-18.2019.
  • Morgan D, Gordon MN, Tan J, Wilcock D, Rojiani AM. Dynamic complexity of the microglial activation response in transgenic models of amyloid deposition: implications for Alzheimer therapeutics. J Neuropathol Exp Neurol. 2005;64(9):743–53. DOI: 10.1097/01.jnen.0000178444.33972.e0.
  • Passamonti L, Tsvetanov KA, Jones P, Bevan-Jones W, Arnold R, Borchert R, et al. Neuroinflammation and functional connectivity in Alzheimer's disease: interactive influences on cognitive performance. J Neurosci. 2019;39(36):7218–26.
  • Abdul HM, Sama MA, Furman JL, Mathis DM, Beckett TL, Weidner AM, et al. Cognitive decline in Alzheimer's disease is associated with selective changes in calcineurin/NFAT signaling. J Neurosci. 2009;29(41):12957–69. DOI: 10.1523/jneurosci.1064-09.2009.
  • Rojanathammanee L, Puig KL, Combs CK. Pomegranate polyphenols and extract inhibit nuclear factor of activated T-cell activity and microglial activation in vitro and in a transgenic mouse model of Alzheimer disease. J Nutr. 2013;143(5):597–605. DOI: 10.3945/jn.112.169516.
  • Essa MM, Subash S, Akbar M, Al-Adawi S, Guillemin GJ. Long-term dietary supplementation of pomegranates, figs and dates alleviate neuroinflammation in a transgenic mouse model of Alzheimer's disease. PLoS One. 2015;10(3):e0120964. DOI: 10.1371/journal.pone.0120964.
  • Du L, Li J, Zhang X, Wang L, Zhang W, Yang M, Hou C. Pomegranate peel polyphenols inhibits inflammation in LPS-induced RAW264.7 macrophages via the suppression of TLR4/NF-κB pathway activation. Food Nutr Res. 2019;63. DOI: 10.29219/fnr.v63.3392.
  • Zhang F, Wu K, Wu X, Xin C, Zhou M, Lei J, Chen J. Punicalagin alleviates brain injury and inflammatory responses, and regulates HO-1/Nrf-2/ARE signaling in rats after experimental intracerebral haemorrhage. Trop J Pharmaceutical Res. 2020;19(4):727–37.
  • Velagapudi R, Baco G, Khela S, Okorji U, Olajide O. Pomegranate inhibits neuroinflammation and amyloidogenesis in IL-1β-stimulated SK-N-SH cells. Eur J Nutr. 2016;55(4):1653–60.
  • Kim YE, Hwang CJ, Lee HP, Kim CS, Son DJ, Ham YW, et al. Inhibitory effect of punicalagin on lipopolysaccharide-induced neuroinflammation, oxidative stress and memory impairment via inhibition of nuclear factor-kappaB. Neuropharmacology. 2017;117:21–32.
  • Asgary S, Karimi R, Joshi T, Kilpatrick KL, Moradi S, Samimi Z, et al. Effect of pomegranate juice on vascular adhesion factors: a systematic review and meta-analysis. Phytomedicine. 2021;80:153359.
  • Kim GH, Kim JE, Rhie SJ, Yoon S. The role of oxidative stress in neurodegenerative diseases. Exp Neurobiol. 2015;24(4):325–40.
  • Rg A. Is there a balance between oxidative stress and antioxidant defense system during development? Med J Islamic Acad Sci. 2005;15(2):55–63.
  • Li H, Hortmann M, Daiber A, Oelze M, Ostad MA, Schwarz PM, et al. Cyclooxygenase 2-selective and nonselective nonsteroidal anti-inflammatory drugs induce oxidative stress by up-regulating vascular NADPH oxidases. J Pharmacol Exp Ther. 2008;326(3):745–53.
  • Tarafdar A, Pula G. The role of NADPH oxidases and oxidative stress in neurodegenerative disorders. Int J Mol Sci. 2018;19(12):3824.
  • Teleanu RI, Chircov C, Grumezescu AM, Volceanov A, Teleanu DM. Antioxidant therapies for neuroprotection – a review. J Clin Med. 2019;8(10):1659.
  • Choi SJ, Lee J-H, Heo HJ, Cho HY, Kim HK, Kim C-J, et al. Punica granatum protects against oxidative stress in PC12 cells and oxidative stress-induced Alzheimer's symptoms in mice. J Med Food. 2011;14(7-8):695–701.
  • Chidambara Murthy KN, Jayaprakasha GK, Singh RP. Studies on antioxidant activity of pomegranate (Punica granatum) peel extract using in vivo models. J Agric Food Chem. 2002;50(17):4791–5.
  • Chen B, Tuuli MG, Longtine MS, Shin JS, Lawrence R, Inder T, Michael Nelson D. Pomegranate juice and punicalagin attenuate oxidative stress and apoptosis in human placenta and in human placental trophoblasts. Am J Physiol-Endocrinol Metabol. 2012;302(9):E1142–52.
  • Moneim AEA. Evaluating the potential role of pomegranate peel in aluminum-induced oxidative stress and histopathological alterations in brain of female rats. Biol Trace Elem Res. 2012;150(1):328–36.
  • Braidy N, Selvaraju S, Essa MM, Vaishnav R, Al-Adawi S, Al-Asmi A, et al. Neuroprotective effects of a variety of pomegranate juice extracts against MPTP-induced cytotoxicity and oxidative stress in human primary neurons. Oxid Med Cell Longevity. 2013;2013:1–12.
  • Subash S, Essa MM, Al-Asmi A, Al-Adawi S, Vaishnav R, Braidy N, et al. Pomegranate from Oman alleviates the brain oxidative damage in transgenic mouse model of Alzheimer’s disease. J Tradit Complement Med. 2014;4(4):232–8.
  • Les F, Prieto JM, Arbonés-Mainar JM, Valero MS, López V. Bioactive properties of commercialised pomegranate (Punica granatum) juice: antioxidant, antiproliferative and enzyme inhibiting activities. Food Funct. 2015;6(6):2049–57.
  • Kandeil MA, Mohammed ET, Hashem KS, Abd El-Wahab RG. Protective effect of pomegranate peel extract against titanium dioxide nanoparticles (TiO). Am J Physiol. 2018;8(2):55–68.
  • Morzelle MC, Salgado JM, Massarioli AP, Bachiega P, de Oliveira Rios A, Alencar SM, et al. Potential benefits of phenolics from pomegranate pulp and peel in Alzheimer’s disease: antioxidant activity and inhibition of acetylcholinesterase. J Food Bioactives. 2019;5:136–41.
  • Pathakoti K, Goodla L, Manubolu M, Tencomnao T. Metabolic alterations and the protective effect of punicalagin against glutamate-induced oxidative toxicity in HT22 cells. Neurotox Res. 2017;31(4):521–31.
  • Harakeh S, Ramadan WS, Al Muhayawi MS, Al Jaouni S, Mousa S, Hakeem KR. Pomegranate peel extract lessens histopathologic changes and restores antioxidant homeostasis in the hippocampus of rats with aluminium chloride-induced Alzheimer’s disease. Asian Pac J Trop Med. 2020;13(10):456.
  • Almuhayawi MS, Ramadan WS, Harakeh S, Al Jaouni SK, Bharali DJ, Mousa SA, Almuhayawi SM. The potential role of pomegranate and its nano-formulations on cerebral neurons in aluminum chloride induced Alzheimer rat model. Saudi J Biol Sci. 2020;27(7):1710–6.
  • Van Harling VN. Radical catcher activities free of methanol fruit leather and pomegranate seeds (Punica granatum. L). J Phys Conf Ser. 2021;1783:012002.
  • Chaubey MG, Chauhan AP, Chokshi PR, Amin RS, Patel SN, Madamwar D, et al. Therapeutic potential of bioactive compounds from Punica granatum extracts against aging and complicity of FOXO orthologue DAF-16 in Caenorhabditis elegans. EXCLI J. 2021;20:80.
  • Giménez-Bastida JA, Ávila-Gálvez MÁ, Espín JC, González-Sarrías A. Evidence for health properties of pomegranate juices and extracts beyond nutrition: a critical systematic review of human studies. Trends Food Sci Technol. 2021;114:410-23.
  • Braidy N, Essa MM, Poljak A, Selvaraju S, Al-Adawi S, Manivasagm T, et al. Consumption of pomegranates improves synaptic function in a transgenic mice model of Alzheimer's disease. Oncotarget. 2016;7(40):64589–604.
  • Cambay Z, Baydas G, Tuzcu M, Bal R. Pomegranate (Punica granatum L.) flower improves learning and memory performances impaired by diabetes mellitus in rats. Acta Physiol Hung. 2011;98(4):409–20.
  • Cochrane SM, Furth AJ. The role of bound lipid and transition metal in the formation of fluorescent advanced glycation endproducts by human serum albumin. Biochem Soc Trans.1993; 21(2):97S.
  • Du Yan S, Chen X, Fu J, Chen M, Zhu H, Roher A, et al. RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease. Nature. 1996;382(6593):685–91.
  • Kumagai Y, Nakatani S, Onodera H, Nagatomo A, Nishida N, Matsuura Y, et al. Anti-glycation effects of Pomegranate (Punica granatum L.) fruit extract and its components in vivo and in vitro. J Agric Food Chem. 2015;63(35):7760–4.
  • Ward MA, Carlsson CM, Trivedi MA, Sager MA, Johnson SC. The effect of body mass index on global brain volume in middle-aged adults: a cross sectional study. BMC Neurol. 2005;5(1):1–7.
  • Willeumier KC, Taylor DV, Amen DG. Elevated BMI is associated with decreased blood flow in the prefrontal cortex using SPECT imaging in healthy adults. Obesity. 2011;19(5):1095–7.
  • Pfohl M, DaSilva NA, Marques E, Agudelo J, Liu C, Goedken M, et al. Hepatoprotective and anti-inflammatory effects of a standardized pomegranate (Punica granatum) fruit extract in high fat diet-induced obese C57BL/6 mice. Int J Food Sci Nutr. 2021; 72(4): 499–510.
  • Patel C, Dadhaniya P, Hingorani L, Soni M. Safety assessment of pomegranate fruit extract: acute and subchronic toxicity studies. Food Chem Toxicol. 2008;46(8):2728–35.
  • Meerts I, Verspeek-Rip C, Buskens C, Keizer H, Bassaganya-Riera J, Jouni Z, et al. Toxicological evaluation of pomegranate seed oil. Food Chem Toxicol. 2009;47(6):1085–92.
  • Ríos J-L, Giner RM, Marín M, Recio MC. A pharmacological update of ellagic acid. Planta Med. 2018;84(15):1068–93.
  • Saeed M, Naveed M, BiBi J, Kamboh AA, Arain MA, Shah QA, et al. The promising pharmacological effects and therapeutic/medicinal applications of Punica granatum L. (Pomegranate) as a functional food in humans and animals. Recent Pat Inflammation Allergy Drug Discovery. 2018;12(1):24–38.
  • Pantuck AJ, Leppert JT, Zomorodian N, Aronson W, Hong J, Barnard RJ, et al. Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer. Clin Cancer Res. 2006;12(13):4018–26.
  • Sohrab G, Roshan H, Ebrahimof S, Nikpayam O, Sotoudeh G, Siasi F. Effects of pomegranate juice consumption on blood pressure and lipid profile in patients with type 2 diabetes: a single-blind randomized clinical trial. Clin Nutr ESPEN. 2019;29:30–35.
  • Banihani SA, Makahleh SM, El-Akawi ZJ. Short-term effect of fresh pomegranate juice on serum cortisol and thyroxine in patients with type 2 diabetes. Curr Mol Med. 2020;20(5):355–60. DOI: 10.2174/1566524019666191129104153
  • Gheflati A, Mohammadi M, Ramezani-Jolfaie N, Heidari Z, Salehi-Abargouei A, Nadjarzadeh A. Does pomegranate consumption affect weight and body composition? A systematic review and meta-analysis of randomized controlled clinical trials. Phytother Res. 2019;33(5):1277–88.
  • González-Sarrías A, Romo-Vaquero M, García-Villalba R, Cortés-Martín A, Selma MV, Espín JC. The Endotoxemia marker lipopolysaccharide-binding protein is reduced in overweight-obese subjects consuming pomegranate extract by modulating the gut microbiota: a Randomized Clinical Trial. Mol Nutrition Food Res. 2018;62(11):e1800160, DOI: 10.1002/mnfr.201800160.
  • Vlachojannis C, Erne P, Schoenenberger AW, Chrubasik-Hausmann S. A critical evaluation of the clinical evidence for pomegranate preparations in the prevention and treatment of cardiovascular diseases. Phytother Res. 2015;29(4):501–8.
  • Sahebkar A, Ferri C, Giorgini P, Bo S, Nachtigal P, Grassi D. Effects of pomegranate juice on blood pressure: a systematic review and meta-analysis of randomized controlled trials. Pharmacol Res. 2017;115:149–61. DOI: 10.1016/j.phrs.2016.11.018.
  • Razani Z, Dastani M, Kazerani HR. Cardioprotective effects of pomegranate (Punica granatum) juice in patients with ischemic heart disease. Phytother Res. 2017;31(11):1731–8. DOI: 10.1002/ptr.5901.
  • Baradaran Rahimi V, Ghadiri M, Ramezani M, Askari VR. Antiinflammatory and anti-cancer activities of pomegranate and its constituent, ellagic acid: evidence from cellular, animal, and clinical studies. Phytother Res. 2020;34(4):685–720.
  • Ammar A, Bailey SJ, Chtourou H, Trabelsi K, Turki M, Hökelmann A, Souissi N. Effects of pomegranate supplementation on exercise performance and post-exercise recovery in healthy adults: a systematic review. Br J Nutr. 2018;120(11):1201–16.
  • Ammar A, Turki M, Hammouda O, Chtourou H, Trabelsi K, Bouaziz M, et al. Effects of pomegranate juice supplementation on oxidative stress biomarkers following weightlifting exercise. Nutrients. 2017;9(8). DOI: 10.3390/nu9080819.
  • Yousefi M, Sadriirani M, PourMahmoudi A, Mahmoodi S, Samimi B, Hosseinikia M, et al. Effects of pomegranate juice (Punica granatum) on inflammatory biomarkers and complete blood count in patients with COVID-19: a structured summary of a study protocol for a randomized clinical trial. Trials. 2021;22(1):246.
  • Ward A, Arrighi HM, Michels S, Cedarbaum JM. Mild cognitive impairment: disparity of incidence and prevalence estimates. Alzheimers Dement. 2012;8(1):14–21.
  • Summers WK, Martin RL, Cunningham M, DeBoynton VL, Marsh GM. Complex antioxidant blend improves memory in community-dwelling seniors. J Alzheimer's Dis. 2010;19(2):429–39.
  • Siddarth P, Li Z, Miller KJ, Ercoli LM, Merril DA, Henning SM, et al. Randomized placebo-controlled study of the memory effects of pomegranate juice in middle-aged and older adults. Am J Clin Nutr. 2020;111(1):170–7.
  • Bellone JA, Murray JR, Jorge P, Fogel TG, Kim M, Wallace DR, Hartman RE. Pomegranate supplementation improves cognitive and functional recovery following ischemic stroke: A randomized trial. Nutr Neurosci. 2019;22(10):738–43.
  • Bookheimer SY, Renner BA, Ekstrom A, Li Z, Henning SM, Brown JA, et al. Pomegranate juice augments memory and FMRI activity in middle-aged and older adults with mild memory complaints. Evidence-Based Complementary Altern Med. 2013;2013:1–14.
  • Ropacki SA, Patel SM, Hartman RE. Pomegranate supplementation protects against memory dysfunction after heart surgery: A pilot study. Evidence-Based Complementary Altern Med. 2013;2013:1–8.
  • EFSA Panel on Dietetic Products, N.; Allergies. Scientific opinion on the substantiation of health claims related to pomegranate/pomegranate juice and maintenance of normal blood cholesterol concentrations (ID 1162, 1320, 2107, 2167), maintenance of normal erectile function (ID 1163), protection of lipids from oxidative damage (ID 1201, 1319, 2123),“antioxidant and anti-aging properties”(ID 1901), increase in appetite after unintentional weight loss leading to an increase in energy intake (ID 2122) and maintenance of normal blood glucose concentrations (ID 4471) pursuant to article 13 (1) of regulation (EC) No 1924/2006. EFSA J. 2010;8(10):1750.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.